CEACAM5 and non-small cell lung carcinoma: Promising data from non-squamous NSCLC patients indicated a correlation between the antitumor activity and the expression level of CEACAM5 (Clinical trial information: NCT02187848; Registration Date: 2014-07-11) 35.